Trial intelligence / Profile preview

Chloroquine for Resistant Chronic Hepatitis C

NCT02058173Phase 4Completed

Sponsor
Shiraz University of Medical Sciences
Start
Jan 2014
Primary completion
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of chloroquine in hepatitis C (HCV), sponsored by Shiraz University of Medical Sciences. Started Jan 2014; status: completed.

02

Drugs

chloroquine
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT02058173.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02058173.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call